(Q43412778)

23 November 2017

Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial (English)

1 reference

23 November 2017

0 references

0 references

0 references

1 reference

1

François Lauzier

1 reference

23 November 2017

Bruno Lévy

2

1 reference

PubMed ID

17019548

23 November 2017

Patrice Lamarre

series ordinal

3

1 reference

PubMed ID

17019548

23 November 2017

Olivier Lesur

series ordinal

4

1 reference

23 November 2017

22 September 2006

1 reference

23 November 2017

Intensive Care Medicine

1 reference

23 November 2017

32

1 reference

23 November 2017

11

1 reference

23 November 2017

1782-1789

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-006-0378-0

23 November 2017

0 references

cites work

Vasopressors for shock

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00134-006-0378-0

Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00134-006-0378-0

Dose-response effects of pressor doses of arginine vasopressin on renal haemodynamics in the rat.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00134-006-0378-0

Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions

21 January 2018

1 reference

12 December 2020

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

1 reference

12 December 2020

Serum vasopressin concentrations in critically ill patients

1 reference

12 December 2020

Direct cardiac effects of vasopressin and their reversal by a vascular antagonist

1 reference

12 December 2020

Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors

1 reference

12 December 2020

Early changes in organ function predict eventual survival in severe sepsis

1 reference

12 December 2020

The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM.

1 reference

12 December 2020

Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats

1 reference

12 December 2020

Arginine vasopressin in 316 patients with advanced vasodilatory shock.

1 reference

12 December 2020

The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis

1 reference

12 December 2020

Human vascular endothelial cells express oxytocin receptors

1 reference

12 December 2020

Low-dose vasopressin in the treatment of vasodilatory septic shock

1 reference

12 December 2020

Deaths: preliminary data for 2003.

1 reference

12 December 2020

A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage

1 reference

12 December 2020

Receptor subtypes involved in relaxation and contraction by arginine vasopressin in canine isolated short posterior ciliary arteries

1 reference

12 December 2020

Vasopressin pressor hypersensitivity in vasodilatory septic shock

1 reference

12 December 2020

Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.

1 reference

12 December 2020

Circulating vasopressin levels in septic shock.

1 reference

12 December 2020

High-dose vasopressin is not superior to norepinephrine in septic shock*

1 reference

12 December 2020

Sepsis in European intensive care units: results of the SOAP study.

1 reference

12 December 2020

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

12 December 2020

Renal microvascular effects of vasopressin and vasopressin antagonists

1 reference

12 December 2020

Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits

1 reference

12 December 2020

Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study

1 reference

12 December 2020

Early goal-directed therapy in the treatment of severe sepsis and septic shock

1 reference

12 December 2020

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

12 December 2020

Comparative effects of vasopressin, norepinephrine, and L-canavanine, a selective inhibitor of inducible nitric oxide synthase, in endotoxic shock

1 reference

12 December 2020

Effects of vasopressin on pulmonary and systemic vascular mechanics.

1 reference

12 December 2020

Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study

1 reference

12 December 2020

Serial evaluation of the SOFA score to predict outcome in critically ill patients

1 reference

12 December 2020

The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock

1 reference

12 December 2020

Beneficial effects of short-term vasopressin infusion during severe septic shock

1 reference

12 December 2020

Vasopressin deficiency contributes to the vasodilation of septic shock

1 reference

12 December 2020

Effects of continuous vasopressin infusion in patients with septic shock

1 reference

12 December 2020

Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock

1 reference

12 December 2020

Arginine vasopressin-induced renal vasodilation mediated by nitric oxide.

1 reference

12 December 2020

The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series

1 reference

12 December 2020

10.1007/S00134-006-0378-0

Identifiers

DOI

1 reference

23 November 2017

1 reference

PubMed ID

17019548